A Fluorescent Photoimmunoconjugate for Imaging of Cholesteatoma

Overview

Journal Sci Rep

Specialty Science

Date 2022 Nov 19

PMID 36402793

Authors

Samuel Early

M Ahsan Saad

Srivalleesha Mallidi

Amer Mansour

Richard Seist

Tayyaba Hasan

Konstantina M Stankovic

Affiliations

Soon will be listed here.

Abstract

Cholesteatoma is a potentially serious complication of chronic ear infections and requires surgical intervention for definitive management. Long-term complications include a frequent need for repeat surgical intervention for disease recurrence, and techniques to improve efficacy of single-stage surgery are an important area of continued research. This study investigates a novel application of the photosensitizer immune conjugate (PIC) cetuximab-benzoporphyrin derivative (Cet-BPD) for in vitro localization of human cholesteatoma tissue, coupled with an in vivo safety study for middle ear application of Cet-BPD in a murine model. In fresh human cholesteatoma tissues, Cet-BPD demonstrates selective localization to the hyperplastic squamous cell tissue associated with cholesteatoma, without localizing to other tissues such as middle ear mucosa. Applied to the murine middle ear, Cet-BPD does not demonstrate any deleterious effect on murine hearing when assessed by any of auditory brainstem response (ABR) thresholds, distortion product otoacoustic emission thresholds, or ABR wave I amplitudes. These findings demonstrate the technical promise and encouraging safety profile for the use of PICs for intraoperative localization and treatment of cholesteatoma.

Citing Articles

Genetic Discovery Enabled by A Large Language Model.

Tu T, Fang Z, Cheng Z, Spasic S, Palepu A, Stankovic K bioRxiv. 2023; .

PMID: 37986848 PMC: 10659415. DOI: 10.1101/2023.11.09.566468.

References

de Boer E, Samuel S, French D, Warram J, Schoeb T, Rosenthal E . Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques. Mol Imaging Biol. 2015; 18(2):232-42. DOI: 10.1007/s11307-015-0892-y. View

Gupta A, Agarwal S . A study of prevalence of cholesteatoma in complications of suppurative otitis media. Indian J Otolaryngol Head Neck Surg. 2012; 50(2):140-6. PMC: 3450986. DOI: 10.1007/BF02991677. View

Presutti L, Gioacchini F, Alicandri-Ciufelli M, Villari D, Marchioni D . Results of endoscopic middle ear surgery for cholesteatoma treatment: a systematic review. Acta Otorhinolaryngol Ital. 2014; 34(3):153-7. PMC: 4035841. View

Rosenthal E, Warram J, de Boer E, Chung T, Korb M, Brandwein-Gensler M . Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res. 2015; 21(16):3658-66. PMC: 4909371. DOI: 10.1158/1078-0432.CCR-14-3284. View

Saad M, Xavierselvan M, Sharif H, Selfridge S, Pawle R, Varvares M . Dual Function Antibody Conjugates for Multimodal Imaging and Photoimmunotherapy of Cancer Cells. Photochem Photobiol. 2021; 98(1):220-231. PMC: 10038131. DOI: 10.1111/php.13501. View

Moffa A, Fiore V, Sabatino L, Cassano M, Tarabichi M, Kapadia M . A 'chemical help' in middle-ear surgery? A systematic review on sodium 2-mercaptoethanesulfonate. J Laryngol Otol. 2021; 135(8):660-667. DOI: 10.1017/S0022215121001535. View

Hansen T . Anesthesia-related neurotoxicity and the developing animal brain is not a significant problem in children. Paediatr Anaesth. 2014; 25(1):65-72. DOI: 10.1111/pan.12548. View

Aker J, Block R, Biddle C . Anesthesia and the developing brain. AANA J. 2015; 83(2):139-47. View

Nath S, Saad M, Pigula M, Swain J, Hasan T . Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease. Cancers (Basel). 2019; 11(12). PMC: 6966499. DOI: 10.3390/cancers11121887. View

10.

Kuo C, Liao W, Shiao A . A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol. 2014; 272(12):3601-9. DOI: 10.1007/s00405-014-3291-0. View

11.

Paparella M, Rybak L . Congenital cholesteatoma. Otolaryngol Clin North Am. 1978; 11(1):113-20. View

12.

Suthakar K, Liberman M . A simple algorithm for objective threshold determination of auditory brainstem responses. Hear Res. 2019; 381:107782. PMC: 6726521. DOI: 10.1016/j.heares.2019.107782. View

13.

Cramer G, Lewis R, Gymarty A, Hagan S, Mickler M, Evans S . Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative-Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. Photochem Photobiol. 2020; 96(3):684-691. DOI: 10.1111/php.13247. View

14.

Rupa V, Jacob A, Joseph A . Chronic suppurative otitis media: prevalence and practices among rural South Indian children. Int J Pediatr Otorhinolaryngol. 1999; 48(3):217-21. DOI: 10.1016/s0165-5876(99)00034-8. View

15.

Wang H, Zhao Q, Zhang Y, Wei J, Wang B, Zheng Z . Efficacy and safety of systemic treatments for patients with recurrent/metastatic head and neck squamous cell carcinoma: A systematic review and network meta-analysis. Pharmacol Res. 2021; 173:105866. DOI: 10.1016/j.phrs.2021.105866. View

16.

He X, Cruz J, Joseph S, Pett N, Chew H, Tuong Z . Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab. Oncotarget. 2018; 9(15):12250-12260. PMC: 5844743. DOI: 10.18632/oncotarget.24242. View

17.

Vergison A, Dagan R, Arguedas A, Bonhoeffer J, Cohen R, Dhooge I . Otitis media and its consequences: beyond the earache. Lancet Infect Dis. 2010; 10(3):195-203. DOI: 10.1016/S1473-3099(10)70012-8. View

18.

Dornelles C, Da Costa S, Meurer L, Schweiger C . Some considerations about acquired adult and pediatric cholesteatomas. Braz J Otorhinolaryngol. 2006; 71(4):536-45. PMC: 9441961. DOI: 10.1016/s1808-8694(15)31212-x. View

19.

Liu W, Ren H, Ren J, Yin T, Hu B, Xie S . The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Mediators Inflamm. 2013; 2013:651207. PMC: 3839121. DOI: 10.1155/2013/651207. View

20.

Crawford K, Pacheco F, Lee Y, Hom M, Rosenthal E, Nguyen Q . A Scoping Review of Ongoing Fluorescence-Guided Surgery Clinical Trials in Otolaryngology. Laryngoscope. 2021; 132(1):36-44. DOI: 10.1002/lary.29891. View